Enhancement of drug absorption by noncharged detergents through membrane and P-glycoprotein binding
暂无分享,去创建一个
[1] Raphael C. Lee,et al. Direct observation of poloxamer 188 insertion into lipid monolayers. , 2002, Biophysical journal.
[2] Kim L R Brouwer,et al. Integration of hepatic drug transporters and phase II metabolizing enzymes: mechanisms of hepatic excretion of sulfate, glucuronide, and glutathione metabolites. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[3] W. Graninger,et al. Tolerability of a new vitamin K1 preparation for parenteral administration to adults: one case of anaphylactoid reaction. , 1987, Clinical therapeutics.
[4] V. Mahler,et al. Polysorbate 80 in medical products and nonimmunologic anaphylactoid reactions. , 2005, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[5] A. E. Senior,et al. Characterization of the ATPase activity of purified Chinese hamster P-glycoprotein. , 1994, Biochemistry.
[6] Anna Seelig,et al. Quantification and characterization of P-glycoprotein-substrate interactions. , 2006, Biochemistry.
[7] Gary Martin,et al. Surfactant Systems: Their Chemistry, Pharmacy and Biology , 1984 .
[8] F. Boess,et al. In vitro investigation on the impact of Solutol HS 15 on the uptake of colchicine into rat hepatocytes. , 2004, International journal of pharmaceutics.
[9] S. Wassall,et al. Deuterium NMR study of the interaction of alpha-tocopherol with a phospholipid model membrane. , 1986, Biochemistry.
[10] Alexander V Kabanov,et al. Pluronic block copolymers as modulators of drug efflux transporter activity in the blood-brain barrier. , 2003, Advanced drug delivery reviews.
[11] B. Roelofsen,et al. Relation between various phospholipase actions on human red cell membranes and the interfacial phospholipid pressure in monolayers. , 1975, Biochimica et biophysica acta.
[12] S. McLaughlin,et al. Effect of monolayer surface pressure on the activities of phosphoinositide-specific phospholipase C-beta 1, -gamma 1, and -delta 1. , 1994, Biochemistry.
[13] J. L. Biedler,et al. Potentiation of drug effect by Tween 80 in Chinese hamster cells resistant to actinomycin D and daunomycin. , 1972, Cancer research.
[14] J. Seelig,et al. Lipid conformation in model membranes and biological membranes , 1980, Quarterly Reviews of Biophysics.
[15] A. Garnier-Suillerot,et al. The effect of crown ethers, tetraalkylammonium salts, and polyoxyethylene amphiphiles on pirarubicin incorporation in K562 resistant cells. , 1995, Biochemical pharmacology.
[16] Ronald T Borchardt,et al. A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro. , 2002, Journal of pharmaceutical sciences.
[17] H. Heerklotz. Triton promotes domain formation in lipid raft mixtures. , 2002, Biophysical journal.
[18] J. Seelig,et al. Interaction of verapamil with lipid membranes and P-glycoprotein: connecting thermodynamics and membrane structure with functional activity. , 2006, Biophysical journal.
[19] C. O’Driscoll,et al. The effects of pluronics block copolymers and Cremophor EL on intestinal lipoprotein processing and the potential link with P-glycoprotein in Caco-2 cells. , 2003, Pharmaceutical research.
[20] G. van Meer,et al. Lipid Traffic: The ABC of Transbilayer Movement , 2000, Traffic.
[21] Y Zhang,et al. The Gut as a Barrier to Drug Absorption , 2001, Clinical pharmacokinetics.
[22] H. Omote,et al. Interaction of transported drugs with the lipid bilayer and P-glycoprotein through a solvation exchange mechanism. , 2006, Biophysical journal.
[23] D. L. Le Couteur,et al. Hyperlipidemia and surfactants: the liver sieve is a link. , 2006, Atherosclerosis.
[24] L M Mir,et al. Effects of detergents on P-glycoprotein atpase activity: differences in perturbations of basal and verapamil-dependent activities. , 1998, Cancer biochemistry biophysics.
[25] M. Gottesman,et al. Is the multidrug transporter a flippase? , 1992, Trends in biochemical sciences.
[26] K. Hirsch‐Ernst,et al. Inhibitors of mdr1-dependent transport activity delay accumulation of the mdr1 substrate rhodamine 123 in primary rat hepatocyte cultures. , 2001, Toxicology.
[27] R. Borchardt,et al. Mechanistic roles of neutral surfactants on concurrent polarized and passive membrane transport of a model peptide in Caco-2 cells. , 1997, Journal of pharmaceutical sciences.
[28] C. Gau,et al. Interactions of Pluronics with phospholipid monolayers at the air-water interface. , 2005, Journal of colloid and interface science.
[29] A. Seelig,et al. Blood-Brain Barrier Permeation: Molecular Parameters Governing Passive Diffusion , 1998, The Journal of Membrane Biology.
[30] A. Seelig,et al. Local anesthetics and pressure: a comparison of dibucaine binding to lipid monolayers and bilayers. , 1987, Biochimica et biophysica acta.
[31] A. Blume,et al. A comparative study of the phase transitions of phospholipid bilayers and monolayers. , 1979, Biochimica et biophysica acta.
[32] Gérard Hopfgartner,et al. P‐Glycoprotein and Surfactants: Effect on Intestinal Talinolol Absorption , 2005, Clinical pharmacology and therapeutics.
[33] V. Ling,et al. Stoichiometry of coupling of rhodamine 123 transport to ATP hydrolysis by P-glycoprotein. , 1998, European journal of biochemistry.
[34] A. Seelig,et al. Structure-activity relationship of P-glycoprotein substrates and modifiers. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[35] J. Huwyler,et al. Improved oral bioavailability of cyclosporin A in male Wistar rats. Comparison of a Solutol HS 15 containing self-dispersing formulation and a microsuspension. , 2002, International journal of pharmaceutics.
[36] J. Silverman,et al. Inhibition of P-Glycoprotein by D-α-Tocopheryl Polyethylene Glycol 1000 Succinate (TPGS) , 1999, Pharmaceutical Research.
[37] A. Seelig,et al. Substrate recognition by P-glycoprotein and the multidrug resistance-associated protein MRP1: a comparison. , 2000, International journal of clinical pharmacology and therapeutics.
[38] Marie-Hélène Dufresne,et al. Block copolymer micelles: preparation, characterization and application in drug delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[39] F. Sharom,et al. Phospholipid flippase activity of the reconstituted P-glycoprotein multidrug transporter. , 2001, Biochemistry.
[40] T. Druley,et al. From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance , 2001, Cellular and Molecular Life Sciences CMLS.
[41] A. Seelig,et al. The rate of P-glycoprotein activation depends on the metabolic state of the cell. , 2004, Biochemistry.
[42] P. Pohl,et al. Ionophoric activity of pluronic block copolymers. , 2004, Biochemistry.
[43] J. Huwyler,et al. Impact of solutol HS 15 on the pharmacokinetic behaviour of colchicine upon intravenous administration to male Wistar rats , 2003, Biopharmaceutics & drug disposition.
[44] Jochem Alsenz,et al. The role of surfactants in the reversal of active transport mediated by multidrug resistance proteins. , 2003, Journal of pharmaceutical sciences.
[45] C. Higgins,et al. Cytoplasmic domains of the transporter associated with antigen processing and P-glycoprotein interact with subunits of the proteasome. , 2005, Molecular immunology.
[46] A. Seelig. A general pattern for substrate recognition by P-glycoprotein. , 1998, European journal of biochemistry.
[47] V. Ling,et al. Effects of nonionic detergents on P-glycoprotein drug binding and reversal of multidrug resistance. , 1993, Cancer research.
[48] N. Melik-Nubarov,et al. Relationship between the structure of amphiphilic copolymers and their ability to disturb lipid bilayers. , 2005, Biochemistry.
[49] Christopher J. H. Porter,et al. An in vitro examination of the impact of polyethylene glycol 400, pluronic P85, and vitamin E d-a-tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein efflux and enterocyte-based metabolism in excised rat intestine , 2002, AAPS PharmSci.
[50] R L Hunter,et al. Bioavailability of tobramycin after oral delivery in FVB mice using CRL-1605 copolymer, an inhibitor of P-glycoprotein. , 2000, Life sciences.
[51] Z. Sauna,et al. Characterization of the Catalytic Cycle of ATP Hydrolysis by Human P-glycoprotein , 2001, The Journal of Biological Chemistry.
[52] Caitriona M. O'Driscoll,et al. The Effects of Pluronic® Block Copolymers and Cremophor® EL on Intestinal Lipoprotein Processing and the Potential Link with P-Glycoprotein in Caco-2 Cells , 2003, Pharmaceutical Research.
[53] M. Sayegh,et al. P-glycoprotein--a novel therapeutic target for immunomodulation in clinical transplantation and autoimmunity? , 2003, Current drug targets.
[54] James E Polli,et al. Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[55] K. Anderson,et al. Reversal of multidrug resistance phenotype by surfactants: relationship to membrane lipid fluidity. , 1995, Archives of biochemistry and biophysics.
[56] M C Willingham,et al. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[57] K. Beyer,et al. Softening of Membrane Bilayers by Detergents Elucidated by Deuterium NMR Spectroscopy , 2000 .
[58] Donald W. Miller,et al. Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies. , 2001, The Journal of pharmacology and experimental therapeutics.
[59] Mark L. Greenberg,et al. Anaphylactoid reactions in children receiving high-dose intravenous cyclosporine for reversal of tumor resistance: the causative role of improper dissolution of Cremophor EL. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[60] A. Seelig. Unraveling membrane-mediated substrate-transporter interactions. , 2006, Biophysical journal.
[61] K. Kjaer,et al. Interaction between lipid monolayers and poloxamer 188: an X-ray reflectivity and diffraction study. , 2005, Biophysical journal.
[62] R L Hunter,et al. Significantly improved oral uptake of amikacin in FVB mice in the presence of CRL-1605 copolymer. , 1999, Life sciences.
[63] R S Weinstein,et al. Solutol HS 15, nontoxic polyoxyethylene esters of 12-hydroxystearic acid, reverses multidrug resistance. , 1991, Cancer research.
[64] D. Putnam,et al. Determination of P-glycoprotein inhibition by excipients and their combinations using an integrated high-throughput process. , 2004, Journal of pharmaceutical sciences.
[65] Guangzhao Mao,et al. Effect of chain lengths of PEO-PPO-PEO on small unilamellar liposome morphology and stability: an AFM investigation. , 2005, Journal of colloid and interface science.
[66] G Ecker,et al. The importance of a nitrogen atom in modulators of multidrug resistance. , 1999, Molecular pharmacology.
[67] A. Rzhetsky,et al. The human ATP-binding cassette (ABC) transporter superfamily. , 2001, Genome research.
[68] T. Litman,et al. Pumping of Drugs by P-Glycoprotein: A Two-Step Process? , 2003, Journal of Pharmacology and Experimental Therapeutics.
[69] W. Sawyer,et al. Reversal of multidrug resistance by surfactants. , 1992, British journal of cancer.
[70] A. Seelig,et al. Real-time monitoring of P-glycoprotein activation in living cells. , 2002, Biochemistry.
[71] J Verweij,et al. Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. , 2001, European journal of cancer.
[72] Y. Tanigawara. Role of P-glycoprotein in drug disposition. , 2000, Therapeutic drug monitoring.
[73] J. Seelig,et al. Correlation of membrane/water partition coefficients of detergents with the critical micelle concentration. , 2000, Biophysical journal.
[74] Terry R Stouch,et al. Progress in understanding the structure-activity relationships of P-glycoprotein. , 2002, Advanced drug delivery reviews.
[75] A. P. Tulloch,et al. A deuterium NMR study of labelled n-alkanol anesthetics in a model membrane. , 1986, Chemistry and physics of lipids.
[76] M. Wenk,et al. Octyl-beta-D-glucopyranoside partitioning into lipid bilayers: thermodynamics of binding and structural changes of the bilayer. , 1997, Biophysical journal.
[77] K. Kjaer,et al. Lipid corralling and poloxamer squeeze-out in membranes. , 2004, Physical review letters.
[78] Y. Lo,et al. Relationships between the hydrophilic-lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[79] M. Sehested,et al. The solvents cremophor EL and Tween 80 modulate daunorubicin resistance in the multidrug resistant Ehrlich ascites tumor. , 1990, Cancer communications.
[80] J. Lankelma,et al. P-glycoprotein drug efflux pump involved in the mechanisms of intrinsic drug resistance in various colon cancer cell lines. Evidence for a saturation of active daunorubicin transport. , 1991, Biochemical pharmacology.
[81] Alexander V. Kabanov,et al. Inhibition of Multidrug Resistance-Associated Protein (MRP) Functional Activity with Pluronic Block Copolymers , 1999, Pharmaceutical Research.
[82] Alexander V. Kabanov,et al. Pluronic P85 Increases Permeability of a Broad Spectrum of Drugs in Polarized BBMEC and Caco-2 Cell Monolayers , 1999, Pharmaceutical Research.
[83] Y. Assaraf,et al. Potentiation of anticancer-drug cytotoxicity by multidrug-resistance chemosensitizers involves alterations in membrane fluidity leading to increased membrane permeability. , 1995, European journal of biochemistry.
[84] H. Omote,et al. Transition State Analysis of the Coupling of Drug Transport to ATP Hydrolysis by P-glycoprotein* , 2003, Journal of Biological Chemistry.
[85] D Mackay,et al. A novel method for measuring membrane-water partition coefficients of hydrophobic organic chemicals: comparison with 1-octanol-water partitioning. , 1988, Journal of Pharmacy and Science.
[86] A. E. Senior,et al. Effects of cardiovascular drugs on ATPase activity of P-glycoprotein in plasma membranes and in purified reconstituted form. , 1998, Biochimica et biophysica acta.
[87] M. Melamed,et al. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[88] Grégori Gerebtzoff,et al. Halogenation of Drugs Enhances Membrane Binding and Permeation , 2004, Chembiochem : a European journal of chemical biology.
[89] A. Seelig,et al. Inhibitors of multidrug efflux transporters: their membrane and protein interactions. , 2005, Mini reviews in medicinal chemistry.
[90] T. Litman,et al. Structure-activity relationships of P-glycoprotein interacting drugs: kinetic characterization of their effects on ATPase activity. , 1997, Biochimica et biophysica acta.
[91] F. Sharom,et al. Interaction of multidrug-resistant Chinese hamster ovary cells with amphiphiles. , 1974, British Journal of Cancer.
[92] Jörg Huwyler,et al. In vitro investigation on the impact of the surface-active excipients Cremophor EL, Tween 80 and Solutol HS 15 on the metabolism of midazolam. , 2004, Biopharmaceutics & drug disposition.
[93] Alberto Guenzi,et al. Improvement of the Bioavailability of Colchicine in Rats by Co-administration of D-α-Tocopherol Polyethylene Glycol 1000 Succinate and a Polyethoxylated Derivative of 12-Hydroxy-Stearic Acid , 2002, Arzneimittelforschung.
[94] Y. Assaraf,et al. Membrane fluidization by ether, other anesthetics, and certain agents abolishes P-glycoprotein ATPase activity and modulates efflux from multidrug-resistant cells. , 1999, European journal of biochemistry.